SynBiotic SE (SBX.DE)
EUR 3.01
(-6.97%)
EUR 3.01
(-6.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -7.58 Million EUR | 55.61% |
| 2022 | -24.61 Million EUR | -85.74% |
| 2021 | -13.25 Million EUR | -1733.86% |
| 2020 | -722.71 Thousand EUR | -5281.73% |
| 2019 | -13.42 Thousand EUR | -1533.7% |
| 2018 | -822.00 EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -10.92 Million EUR | 55.61% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q2 | -1.24 Million EUR | 0.0% |
| 2022 Q4 | - EUR | 100.0% |
| 2022 FY | -24.61 Million EUR | -85.74% |
| 2021 FY | -13.25 Million EUR | -1733.86% |
| 2021 Q2 | -491.29 Thousand EUR | 35.47% |
| 2020 Q2 | -97.46 Thousand EUR | 0.0% |
| 2020 FY | -722.71 Thousand EUR | -5281.73% |
| 2020 Q4 | -761.34 Thousand EUR | -681.18% |
| 2019 FY | -13.42 Thousand EUR | -1533.7% |
| 2018 FY | -822.00 EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| MPH Health Care AG | 15.7 Million EUR | 148.293% |
| Apontis Pharma AG | -15.1 Million EUR | 49.788% |
| Dermapharm Holding SE | 182.89 Million EUR | 104.146% |
| Evotec SE | -47.5 Million EUR | 84.04% |
| MERCK Kommanditgesellschaft auf Aktien | 3.6 Billion EUR | 100.21% |
| PharmaSGP Holding SE | 40.91 Million EUR | 118.531% |